|
Results of antimycotic prophylaxis with posaconazole in patients with severe graft-versus-host disease (GVHD): a single centre analysis (click for details) |
|
|
|
Changing face of invasive Aspergillus infections in children undergoing haematopoietic stem cell transplantation: a single centre observational study over 20 years (click for details) |
|
|
|
Clinical evaluation of secondary posaconazole prophylaxis in the initial neutropenic phase of allo-HSCT: a small case series from a single unit (click for details) |
|
|
|
Randomized trial of prophylaxis with intravenous micafungin during haematopoietic stem cell transplantation (click for details) |
|
|
|
Clinical efficacy and management of primary antifungal prophylaxis with posaconazole in high-risk haematology patients (click for details) |
|
|
|
Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haploidentical haematopoietic stem cell transplant (click for details) |
|
|
|
Fungal colonization, emergence of resistant strains, and breakthrough invasive fungal infections during antifungal prophylaxis with micafungin in patients with leukaemia and stem cell transplant recipients. A retrospective single centre analysis (click for details) |
|
|
|
A survey of infectious disease clinical practices among paediatric blood and marrow transplant programmes in the United States (click for details) |
|
|
|
Autologous haematopoietic stem cell transplantation following high-dose immunosuppressive therapy in neuromyelitis optica (click for details) |
|
|
|
Computed tomography pulmonary angiography (CTPA) for the diagnosis of invasive mould disease in recipients of allogeneic haematopoietic stem cell transplantation (click for details) |
|
|
